Tioga Pharmaceuticals Inc - 92121 San Diego, CA

Business Name: Tioga Pharmaceuticals Inc
Categorized In:
Address: 9393 Towne Center Drive # 200, San Diego, CA 92121
Phone Number: (858) 677-6077
Contact Person: David Urso
Website Address: forwardventures.com
NAICS Code: 325412
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 2005
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Mirati Therapeutics - San Diego, CA 92121
Amplyx Pharmaceuticals Inc - San Diego, CA 92121
Depotech Corp - San Diego, CA 92121
Pacira Pharmaceuticals Inc - San Diego, CA 92121
Amylin Ohio LLC - San Diego, CA 92121
Conatus Pharmaceuticals Inc - San Diego, CA 92121
Novomedix - San Diego, CA 92121
Coda Therapeutics Inc - San Diego, CA 92121
Bioserv Corp - San Diego, CA 92121
Proprius Inc - San Diego, CA 92121
Arena Pharmaceuticals Inc - San Diego, CA 92121
Amaze Therapeutics - San Diego, CA 92121
Formex LLC - San Diego, CA 92121
Prometheus Rxdx Inc - San Diego, CA 92121
Neuropore Therapies - San Diego, CA 92121
Regulus Therapeutics Inc - San Diego, CA 92121
Skyepharma Inc - San Diego, CA 92121
Phage Biotechnology Corporation - San Diego, CA 92121
Advanced Molecular Design Inc - San Diego, CA 92121
Epigen Biosciences Inc - San Diego, CA 92121

Tioga Pharmaceuticals Inc provides professional from its single location at the coordinates 32.877634,-117.207291.

The company offers BOTH variables under the SIC code 2834 and NAICS code 325412, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2005, the company can now be visited at 9393 Towne Center Drive # 200, San Diego, California 92121 or contacted through representative David Urso at (858) 677-6077.

For frequently asked questions and further inquiries about professional , get to know more about Tioga Pharmaceuticals Inc through its company website at forwardventures.com. Engage with this business on its social media platforms through on Twitter and on Facebook.